We are excited to host our hybrid Clinical Research Conference in Dallas, Texas! We are bringing together treating physicians, care teams, researchers, and families to share the latest updates on SLC13A5 Epilepsy (Citrate Transporter Disorder). This will also help our community prepare for upcoming clinical trials.
We look forward to seeing you virtually or in-person!
In-person registration closes: May 31, 2022